Combined PTEN Mutation and Protein Expression Associate with Overall and Disease-Free Survival of Glioblastoma Patients.
about
Focus on PTEN RegulationLong-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature reviewSomatic mutations associated with MRI-derived volumetric features in glioblastomaRedox Regulation of the Tumor Suppressor PTEN by Hydrogen Peroxide and Tert-Butyl Hydroperoxide.Emerging treatment strategies for glioblastoma multiformeDerivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic AllelesCurrent clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.PREX2 promotes the proliferation, invasion and migration of pancreatic cancer cells by modulating the PI3K signaling pathway.Current Advances in Checkpoint Inhibitors: Lessons from Non-Central Nervous System Cancers and Potential for Glioblastoma.PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysisDEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method.PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase.
P2860
Q26797287-6193286F-805C-485E-8079-3FA542B50F74Q27026704-C90E6530-2902-41A1-B32B-B3EDF96D906EQ28607337-CA1B81BF-3EB6-478B-B50B-641A81010C4CQ33755023-54942818-4EA1-4FEF-AF26-6B934407F806Q34542656-141CEE15-3061-4A3A-A4EC-D634F7A9E4B4Q35859325-28AC47D2-0BBA-40BB-B6F1-1AFDB13D28DEQ36009016-F061C40A-2603-42B9-B999-87E6A90E50ACQ38242086-020332A9-53B1-4305-BCEB-F99A3B5783E6Q38601004-6ABA4098-7032-4213-8A83-DC9A8A6211E9Q38756476-8DFA3207-FAF2-4464-9706-6460B1D5F471Q39449408-E48A25E7-2DC2-4908-AB14-047D4DC2DF5DQ39640325-2495AFCF-4519-436B-8CB9-7A17AA0BC7D9Q41145800-901C6A65-DCAD-4561-9CD8-9962ECD9171BQ47131994-C6F29972-5BDA-4F50-A597-4744403C2058Q50998090-3B164D24-7DB7-4846-8BCA-F54D22861832
P2860
Combined PTEN Mutation and Protein Expression Associate with Overall and Disease-Free Survival of Glioblastoma Patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Combined PTEN Mutation and Pro ...... ival of Glioblastoma Patients.
@ast
Combined PTEN Mutation and Pro ...... ival of Glioblastoma Patients.
@en
type
label
Combined PTEN Mutation and Pro ...... ival of Glioblastoma Patients.
@ast
Combined PTEN Mutation and Pro ...... ival of Glioblastoma Patients.
@en
prefLabel
Combined PTEN Mutation and Pro ...... ival of Glioblastoma Patients.
@ast
Combined PTEN Mutation and Pro ...... ival of Glioblastoma Patients.
@en
P2093
P2860
P1476
Combined PTEN Mutation and Pro ...... ival of Glioblastoma Patients.
@en
P2093
Haoyan Chen
Jilin Wang
Jing-Yuan Fang
P2860
P304
196-205.e1
P356
10.1016/J.TRANON.2014.02.004
P577
2014-03-04T00:00:00Z